The present invention is directed to compounds according to formula, (R2R3)-A0A1-c(A2-A3-A4-A5-A6-A7-A8-A9)-A10-R1, wherein the definitions of A1 to A10 and R1 to R3 are provided in the application, and pharmaceutically-acceptable salts thereof, that act as ligands for one or more of the melanocortin receptors, to methods of using such compounds to treat mammals, and to pharmaceutical compositions comprising said compounds.
展开▼
